243 related articles for article (PubMed ID: 28628466)
21. [Novel autoantibodies in inflammatory myopathies and systemic sclerosis].
Ribi C
Rev Med Suisse; 2015 Jan; 11(456-457):25-9. PubMed ID: 25799647
[TBL] [Abstract][Full Text] [Related]
22. Clinical correlates of monospecific anti-PM75 and anti-PM100 antibodies in a tri-nation cohort of 1574 systemic sclerosis subjects.
Wodkowski M; Hudson M; Proudman S; Walker J; Stevens W; Nikpour M; Assassi S; Mayes MD; Tatibouet S; Wang M; ; ; ; Baron M; Fritzler MJ
Autoimmunity; 2015; 48(8):542-51. PubMed ID: 26334795
[TBL] [Abstract][Full Text] [Related]
23. Malignancies in Patients with Anti-RNA Polymerase III Antibodies and Systemic Sclerosis: Analysis of the EULAR Scleroderma Trials and Research Cohort and Possible Recommendations for Screening.
Lazzaroni MG; Cavazzana I; Colombo E; Dobrota R; Hernandez J; Hesselstrand R; Varju C; Nagy G; Smith V; Caramaschi P; Riccieri V; Hachulla E; Balbir-Gurman A; Chatelus E; Romanowska-Próchnicka K; Araújo AC; Distler O; Allanore Y; Airò P;
J Rheumatol; 2017 May; 44(5):639-647. PubMed ID: 28089973
[TBL] [Abstract][Full Text] [Related]
24. Specific autoantibodies in dermatomyositis: a helpful tool to classify different clinical subsets.
Merlo G; Clapasson A; Cozzani E; Sanna L; Pesce G; Bagnasco M; Burlando M; Parodi A
Arch Dermatol Res; 2017 Mar; 309(2):87-95. PubMed ID: 27928683
[TBL] [Abstract][Full Text] [Related]
25. The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis.
Chinoy H; Fertig N; Oddis CV; Ollier WE; Cooper RG
Ann Rheum Dis; 2007 Oct; 66(10):1345-9. PubMed ID: 17392346
[TBL] [Abstract][Full Text] [Related]
26. Systemic autoimmune rheumatic diseases as paraneoplastic phenomena: 3 illustrative case reports and narrative review of the literature.
Poelman A; Neerinckx B; Beuselinck B; De Langhe E
Acta Clin Belg; 2023 Oct; 78(5):410-417. PubMed ID: 36847475
[TBL] [Abstract][Full Text] [Related]
27. Strong correlation between cancer progression and anti-transcription intermediary factor 1γ antibodies in dermatomyositis patients.
Ogawa-Momohara M; Muro Y; Mitsuma T; Katayama M; Yanaba K; Nara M; Kakeda M; Kono M; Akiyama M
Clin Exp Rheumatol; 2018; 36(6):990-995. PubMed ID: 29745874
[TBL] [Abstract][Full Text] [Related]
28. A case of anti-PL-7 antibody-positive anti-synthetase syndrome with dermatomyositis-associated erythema induced sclerodermatous changes.
Fukuzono M; Sasaki K; Ichimura Y; Inoue S; Iwasaki R; Imai H; Saito A; Kubota N; Tanaka R; Nakamura Y; Fujisawa Y; Fujimoto M; Nomura T; Okiyama N
Rheumatology (Oxford); 2021 Oct; 60(10):e362-e364. PubMed ID: 33892494
[No Abstract] [Full Text] [Related]
29. Survival in systemic sclerosis-pulmonary arterial hypertension by serum autoantibody status in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) Registry.
Hinchcliff M; Khanna S; Hsu VM; Lee J; Almagor O; Chang RW; Steen V; Chung L;
Semin Arthritis Rheum; 2015 Dec; 45(3):309-14. PubMed ID: 26210782
[TBL] [Abstract][Full Text] [Related]
30. [Spectrum of antinuclear and anti-cytoplasmic antibodies in dermatomyositis and polymyositis overlap syndromes].
Meurer M; Hausmann-Martinez-Pardo G; Braun-Falco O
Hautarzt; 1989 Oct; 40(10):623-9. PubMed ID: 2482267
[TBL] [Abstract][Full Text] [Related]
31. Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis.
Baroni SS; Santillo M; Bevilacqua F; Luchetti M; Spadoni T; Mancini M; Fraticelli P; Sambo P; Funaro A; Kazlauskas A; Avvedimento EV; Gabrielli A
N Engl J Med; 2006 Jun; 354(25):2667-76. PubMed ID: 16790699
[TBL] [Abstract][Full Text] [Related]
32. Association of Anti-CCAR1 Autoantibodies With Decreased Cancer Risk Relative to the General Population in Patients With Anti-Transcriptional Intermediary Factor 1γ-Positive Dermatomyositis.
Fiorentino D; Mecoli CA; Igusa T; Albayda J; Paik JJ; Tiniakou E; Adler B; Mammen AL; Shah AA; Rosen A; Christopher-Stine L; Casciola-Rosen L
Arthritis Rheumatol; 2023 Jul; 75(7):1238-1245. PubMed ID: 36762496
[TBL] [Abstract][Full Text] [Related]
33. [Retrospective analysis of anti-TIF1gamma, anti-NXP2 and anti-SAE1/2 antibodies carriers at Bordeaux university hospital from November 2014 to February 2017].
Victor J; Zanardo L; Héron-Mermin D; Poursac N; Solé G; Bordes C; Duffau P
Rev Med Interne; 2019 Feb; 40(2):70-81. PubMed ID: 30527961
[TBL] [Abstract][Full Text] [Related]
34. Myositis and interstitial lung disease associated with autoantibody to a transfer RNA-related protein Wa.
Kajihara M; Kuwana M; Tokuda H; Yamane K; Kubo M; Hirakata M; Mimori T
J Rheumatol; 2000 Nov; 27(11):2707-10. PubMed ID: 11093458
[TBL] [Abstract][Full Text] [Related]
35. The IgG2 Isotype of Anti-Transcription Intermediary Factor 1γ Autoantibodies Is a Biomarker of Cancer and Mortality in Adult Dermatomyositis.
Aussy A; Fréret M; Gallay L; Bessis D; Vincent T; Jullien D; Drouot L; Jouen F; Joly P; Marie I; Meyer A; Sibilia J; Bader-Meunier B; Hachulla E; Hamidou M; Huë S; Charuel JL; Fabien N; Viailly PJ; Allenbach Y; Benveniste O; Cordel N; Boyer O;
Arthritis Rheumatol; 2019 Aug; 71(8):1360-1370. PubMed ID: 30896088
[TBL] [Abstract][Full Text] [Related]
36. Dermatomyositis and Immune-Mediated Necrotizing Myopathies: A Window on Autoimmunity and Cancer.
Aussy A; Boyer O; Cordel N
Front Immunol; 2017; 8():992. PubMed ID: 28871260
[TBL] [Abstract][Full Text] [Related]
37. [Dermatomyositis-specific antibodies].
Bodoki L; Nagy-Vincze M; Griger Z; Dankó K
Z Rheumatol; 2015 May; 74(4):363-9. PubMed ID: 25644067
[TBL] [Abstract][Full Text] [Related]
38. Prevalence and clinical associations of anti-Ku antibodies in patients with systemic sclerosis: a European EUSTAR-initiated multi-centre case-control study.
Rozman B; Cucnik S; Sodin-Semrl S; Czirják L; Varjú C; Distler O; Huscher D; Aringer M; Steiner G; Matucci-Cerinic M; Guiducci S; Stamenkovic B; Stankovic A; Kveder T
Ann Rheum Dis; 2008 Sep; 67(9):1282-6. PubMed ID: 18063672
[TBL] [Abstract][Full Text] [Related]
39. Anti-signal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathy.
Kao AH; Lacomis D; Lucas M; Fertig N; Oddis CV
Arthritis Rheum; 2004 Jan; 50(1):209-15. PubMed ID: 14730618
[TBL] [Abstract][Full Text] [Related]
40. [Risk factors for cancer in patients with myositis. Clinical, immunological characteristics and the role of the anti-p155/140 antibody].
Szankai Z; Nagy-Vincze M; Bodoki L; Jakab A; Betteridge Z; Dankó K
Orv Hetil; 2014 Sep; 155(36):1437-44. PubMed ID: 25176518
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]